Important limitations on this safety profile: the longest trial was 24 weeks, the total trial population is small by modern standards, and the clinical trials used oral dosing
These findings provide a solid foundation for future research aimed at translating these results into therapeutic applications
In a 71-week double-blind, placebo-controlled trial, 27.9% of participants with overweight or obesity taking oral semaglutide 25 mg lost 20% body weight at week 64, compared to 3.1% of the placebo group
It is not approved, and regulators have warned against unlicensed versions sold online
Research Applications NNMT Enzyme Inhibition Studied as a selective enzyme inhibitor: NNMT activity enzyme-inhibition research Methylation capacity SAM-cycle studies Enzyme kinetics inhibitor characterization NAD+ & Methylation Metabolism Examined in cellular-metabolism models: NAD+ salvage cofactor-regeneration research SAM cycle methyl-donor metabolism Cellular energetics metabolic signaling Adipocyte Metabolism Investigated in fat-cell research: Adipocyte function cellular-metabolism models Lipid handling metabolic research Metabolic Regulation Explored in energy-balance models: Diet-induced obesity preclinical models Metabolic disease research investigation Storage & Handling Guidelines Capsule Storage Store in a cool, dry place at room temperature (1525C) Keep in the original sealed container , away from light and moisture Retain any desiccant packet included in the bottle Keep the container tightly closed between uses Handling Guidelines No reconstitution, solvents, or mixing required Handle capsules with clean, dry hands Do not open, crush, or split the capsules Keep away from heat and out of reach of children Shelf Life & Stability Stable at room temperature when stored as directed Avoid excessive heat, humidity, and direct sunlight Reseal the container promptly after each use Use before the labeled expiration date 5-Amino-1MQ is a stable small-molecule salt
